Arcadia Biosciences (RKDA) Misses Q3 EPS by 2c

Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $1.08 million versus the consensus estimate of $2.1 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M